CARBAZOL DERIVATIVES FOR USE IN OPTOELECTRONIC DEVICES

DE502019012360D1Active Publication Date: 2024-11-07SAMSUNG DISPLAY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE502019012360
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-12-28
Filing Date
2019-11-08
Publication Date
2024-11-07
Estimated Expiration
2039-11-08

AI Technical Summary

Technical Problem

Current organic light-emitting diodes (OLEDs) face challenges in achieving high efficiency and stability due to limitations in emitter materials, particularly in the blue and sky blue spectral range, with existing materials often having lower photoluminescence quantum yields and shorter excited state lifetimes.

Method used

Development of purely organic molecules with emission maxima between 420 nm and 520 nm, specifically designed to exhibit thermally activated delayed fluorescence (TADF), offering high photoluminescence quantum yields of 70% and more, and improved stability through specific chemical structures and synthesis methods.

Benefits of technology

These organic molecules enhance the efficiency and stability of OLEDs, providing comparable or superior color characteristics while extending the excited state lifetime, leading to improved performance in optoelectronic devices.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The invention relates to organic molecules and their use in organic light-emitting diodes (OLEDs) and other optoelectronic devices. State of the art

[0002] WO 2013 / 100540 A1 relates to a compound for an organic optoelectronic device represented by the chemical formula 1: Ar 3< , L 3< , L, L 2< ; Ar 2< , m3, m2, n3 and n2 are as defined in WO 2013 / 100540 A1. L is represented by the following chemical formulas 2-4: where Ar 1< , L 1< , R 1< , R 2< , n1, m1 and * are as defined in WO 2013 / 100540 A1.

[0003] EP 3 109 247 A1 relates to a condensed cyclic compound and an organic light-emitting device containing this compound. The cyclic compound is represented by Formula 1: where A 1 , R 31 , X 1 -X 18 , L 1< , L 2 , a1, a2, b1, c1 are as defined in EP 3 109 247 A1.

[0004] WO 2016 / 013875 A1 discloses an organic electroluminescent device comprising an anode, a cathode, and an organic layer between the anode and the cathode, wherein the organic layer comprises one or more light-emitting layers and one or more hole-transport layers; at least one light-emitting layer comprises one or more dopant compounds and two or more host compounds; a first host compound is represented by the following formula 1; a second host compound is represented by the following formula 2; and at least one hole-transport layer comprising the compound represented by the following formula 3: where A 1 -A 3 , X 1 -X 18 , Xa-Xh, La, Ma, L 1< , L 2 , R 1 -R 4 , r1-r4, m and I are as defined in WO 2016 / 013875 A1.

[0005] WO 2015 / 142036 A1 describes an electron buffer material comprising a compound containing a nitrogen-containing heteroaryl selected from the compounds represented by the following formulas 1 to 3: H-(Cz-L 1 ) a -M ------------- (1) H-(Cz) b -L 1 -M ------------- (2) where Cz represents the following structure: A represents: B represents: C represents: where X 1 -X 3 , R 1 -R 5 , ag, L 1< , Y and M are as defined in WO 2015 / 142036 A1.

[0006] WO 2013 / 165192 A1 relates to an organic electroluminescent compound represented by the following formula 1 where L 1< , L 2 , X 1 , X 2 , R 1 -R 6 , ad are as defined in WO 2013 / 165192 A1. Description

[0007] The object of the present invention is to provide molecules suitable for use in optoelectronic devices.

[0008] This problem is solved by the invention, which provides a new class of organic molecules.

[0009] According to the invention, the organic molecules are purely organic molecules, i.e., unlike metal complexes known for their use in optoelectronic devices, they do not contain metal ions.

[0010] According to the present invention, the organic molecules exhibit emission maxima in the blue, sky blue, or green spectral range. The organic molecules exhibit emission maxima in particular between 420 nm and 520 nm, preferably between 440 nm and 495 nm, more preferably between 450 nm and 470 nm. The photoluminescence quantum yields of the organic molecules according to the invention are in particular 70% or more. The molecules according to the invention exhibit, in particular, thermally activated delayed fluorescence (TADF). The use of the molecules according to the invention in an optoelectronic device, for example, an organic light-emitting diode (OLED), leads to higher device efficiencies. Corresponding OLEDs exhibit greater stability than OLEDs with known emitter materials and comparable colors.

[0011] The organic molecule according to the invention is selected from the group consisting of formula Ila-1, formula Ila-2 and formula Ila-3: where X is selected from the group consisting of H, SiMe 3 , SiPh 3 , CN and CF 3 ; Ar EWG< is selected from the group consisting of the formulas IIa to IIc and IIi where # represents the bond site of a single bond connecting Ar EWG< to the phenyl ring; R 1< is independently selected at each occurrence from the group consisting of hydrogen, deuterium, C 1 -C 5 alkyl, wherein one or more hydrogen atoms are optionally substituted by deuterium; C 2 -C 8 alkenyl, wherein one or more hydrogen atoms are optionally substituted by deuterium; C 2 -C 8 alkynyl, wherein one or more hydrogen atoms are optionally substituted by deuterium; and C 6 -C 18 aryl, which is optionally substituted with one or more substituents R 6< ; R 2< is independently selected at each occurrence from the group consisting of hydrogen, deuterium, C 1 -C 5 alkyl, wherein one or more hydrogen atoms are optionally substituted by deuterium; C 2 -C 8 alkenyl, wherein one or more hydrogen atoms are optionally substituted by deuterium;C 2 -C 8 alkynyl, wherein one or more hydrogen atoms are optionally substituted by deuterium; and C 6 -C 18 aryl, which is optionally substituted by one or more substituents R 6< ; R d< at each occurrence is independently selected from the group consisting of hydrogen, deuterium, N(R 6< ) 2 , OR 6< , Si(R 6< ) 3 , B(OR 6< ) 2 , OSO 2 R 6< , CF 3 , CN, F, Br, I, C 1 -C 40 alkyl, which is optionally substituted with one or more substituents R 6< and wherein one or more non-adjacent CH 2 groups are optionally substituted by R 6< C=CR 6< , C· C, Si(R 6< ) 2 , Ge(R 6< ) 2 , Sn(R 6< ) 2 , C=O, C=S, C=Se, C=NR 6< , P(=O)(R 6< ), SO, SO 2 , NR 6< , O, S or CONR 6< ;C 1 -C 40 alkoxy which is optionally substituted with one or more substituents R 6< and wherein one or more non-adjacent CH 2 groups are optionally substituted by R 6< C=CR 6< , C· C, Si(R 6< ) 2 , Ge(R 6< ) 2 , Sn(R 6< ) 2 , C=O, C=S, C=Se, C=NR 6< , P(=O)(R 6< ), SO, SO 2 , NR 6< , O, S or CONR 6< ; C 1 -C 40 -thioalkoxy which is optionally substituted with one or more substituents R 6< and wherein one or more non-adjacent CH 2 groups are optionally substituted by R 6< C=CR 6< , C· C, Si(R 6< ) 2 , Ge(R 6< ) 2 , Sn(R 6< ) 2 , C=O, C=S, C=Se, C=NR 6< , P(=O)(R 6< ), SO, SO 2 , NR 6< , O, S or CONR 6< ; C 2 -C 40 alkenyl which is optionally substituted by one or more substituents R 6< and wherein one or more non-adjacent CH 2 groups are optionally substituted by R 6< C=CR 6< , C· C, Si(R 6< ) 2 , Ge(R 6< ) 2 , Sn(R 6< ) 2 , C=O, C=S, C=Se, C=NR 6< , P(=O)(R 6< ), SO, SO 2 , NR 6< , O, S or CONR 6< ;C 2 -C 40 alkynyl which is optionally substituted by one or more substituents R 6< and wherein one or more non-adjacent CH 2 groups are optionally substituted by R 6<, C=CR 6<, C· C, Si(R 6<) 2, Ge(R 6<) 2, Sn(R 6<) 2, C=O, C=S, C=Se, C=NR 6<, P(=O)(R 6<), SO, SO 2, NR 6<, O, S or CONR 6<; C 6 -C 60 aryl which is optionally substituted by one or more substituents R 6<; and C 3 -C 57 heteroaryl which is optionally substituted by one or more substituents R 6<; R 6< is independently selected at each occurrence from the group consisting of hydrogen, deuterium, OPh, CF 3 , CN, F, C 1 -C 5 alkyl, optionally wherein one or more hydrogen atoms are independently substituted by deuterium, CN, CF 3 or F; C 1 -C 5 alkoxy, optionally wherein one or more hydrogen atoms are independently substituted by deuterium, CN, CF 3 or F;C 1 -C 5 -thioalkoxy, wherein optionally one or more hydrogen atoms are independently substituted by deuterium, CN, CF 3 or F; C 2 -C 5 -alkenyl, wherein optionally one or more hydrogen atoms are independently substituted by deuterium, CN, CF 3 or F; C 2 -C 5 -alkynyl, wherein optionally one or more hydrogen atoms are independently substituted by deuterium, CN, CF 3 or F; C 6 -C 18 -aryl, which is optionally substituted with one or more C 1 -C 5 -alkyl substituents; C 3 -C 17 -heteroaryl, which is optionally substituted with one or more C 1 -C 5 -alkyl substituents; N(C 6 -C 18 -aryl) 2 ; N(C 3 -C 17 -heteroaryl) 2 , and N(C 3 -C 17 -heteroaryl)(C 6 -C 18 -aryl); RA< at each occurrence, is independently selected from a chemical structure of the formula IIA ; or a chemical structure of formula IIB where RN< is selected from the group consisting of Me, i< Pr, t< Bu, CN, CF 3 and Ph; where $ represents the binding site of a single bond by means of which RA< is attached. where RB< is selected from the group consisting of H, Ph, CN, CF 3 , from a chemical structure of formula IIA-2 or a chemical structure of the formula IIB-2 where RN#< is selected from the group consisting of Me, i< Pr, t< Bu, CN, CF 3 and Ph; where S represents the binding site of a single bond and.where R b< is independently selected at each occurrence from the group consisting of: H, Me, i< Pr, t< Bu, CN, CF 3 , Ph, which is optionally substituted with one or more substituents independently selected from the group consisting of Me, i< Pr, t< Bu, CN, CF 3 and Ph, pyridinyl, which is optionally substituted with one or more substituents independently selected from the group consisting of Me, i< Pr, t< Bu, CN, CF 3 and Ph, pyrimidinyl, which is optionally substituted with one or more substituents independently selected from the group consisting of Me, i< Pr, t< Bu, CN, CF 3 and Ph, carbazolyl, which is optionally substituted with one or more substituents independently selected from the group consisting of Me, i< Pr, t< Bu, CN, CF 3 and Ph, triazinyl, which is optionally substituted with one or more substituents independently selected from the group consisting from Me, i< Pr, t< Bu, CN, CF 3 and Ph, and N(Ph) 2 . .

[0012] In one embodiment of the invention, R 1< is independently at each occurrence C 6 -C 18 aryl, optionally substituted with one or more substituents R 6< .

[0013] In one embodiment of the invention, R 1< is independently selected at each occurrence from the group consisting of phenyl (Ph), optionally substituted with one or more substituents R 6< .

[0014] In one embodiment of the invention, R 1< is phenyl.

[0015] In one embodiment of the invention, RN< is phenyl.

[0016] In one embodiment of the invention, RN#< is phenyl.

[0017] In one embodiment of the invention, R 2< is independently selected at each occurrence from the group consisting of Hydrogen, CN, CF 3 and C 6 -C 18 aryl, which is optionally substituted with one or more substituents R 6< .

[0018] In one embodiment of the invention, R 2< is independently selected at each occurrence from the group consisting of Hydrogen, CN, CF 3 and phenyl, which is optionally substituted with one or more substituents R 6< .

[0019] In one embodiment of the invention, R 2< is independently selected at each occurrence from the group consisting of hydrogen, CN, CF 3 and phenyl.

[0020] In one embodiment of the invention, R 2< is independently selected at each occurrence from the group consisting of hydrogen, CN and CF 3 .

[0021] In one embodiment of the invention, R 2< is independently selected at each occurrence from the group consisting of hydrogen and CN.

[0022] In one embodiment of the invention, R 2< is hydrogen at each occurrence.

[0023] In one embodiment of the organic molecules, R 1< is at each occurrence independently Phenyl optionally substituted with one or more substituents R 6< , and R 2< , which at each occurrence is independently selected from the group consisting of hydrogen, CN, CF 3 and phenyl optionally substituted with one or more substituents R 6< .

[0024] In one embodiment of the organic molecules, R 1< is phenyl at each occurrence, R 2< is independently selected at each occurrence from the group consisting of hydrogen, CN, CF 3 and phenyl; RN< is at each occurrence phenyl, and RN#< is at each occurrence phenyl.

[0025] In one embodiment of the organic molecules, R 1< is phenyl at each occurrence, R 2< is hydrogen at each occurrence, RN< is phenyl at each occurrence; and RN#< is phenyl at each occurrence.

[0026] In one embodiment, R 6< is selected from the group consisting of Me, i< Pr, t< Bu, CN, CF 3 and Ph.

[0027] In one embodiment, X is selected from the group consisting of SiMe 3 , SiPh 3 , CN and CF 3 .

[0028] In a preferred embodiment, X is selected from the group consisting of CN and CF 3 .

[0029] In a preferred embodiment, X is CN.

[0030] In one embodiment, RB< is selected from the group consisting of H, Ph, CN, CF 3 , or a chemical structure of the formula IIB-2 where RN#< is selected from the group consisting of Me, i< Pr, t< Bu, CN, CF 3 and Ph.

[0031] In one embodiment, RB< is selected from the group consisting of H, Ph, CN, CF 3 , or a chemical structure of the formula IIB-2 where RN#< equals Ph.

[0032] In one embodiment, RB< is selected from the group consisting of H, Ph, CN, or a chemical structure of formula IIB-2 where RN#< equals Ph.

[0033] In one embodiment, RB< is selected from the group consisting of H, or a chemical structure of the formula IIB-2 where RN#< equals Ph.

[0034] In one embodiment, RB< is equal to H.

[0035] In one embodiment, RB< is composed of a chemical structure of formula IIB-2 where RN#< equals Ph.

[0036] In a further preferred embodiment, RB< is selected from the group consisting of H, or a chemical structure of the formula IIB-2 where RN#< equals Ph.

[0037] The organic molecules according to the invention comprise or consist of a structure selected from the group consisting of Formula Ila-1, Formula Ila-2, and Formula Ila-3: where R b< at each occurrence is independently selected from the group consisting of H, Me, i<Pr, t<Bu, CN, CF3, Ph, which is optionally substituted with one or more substituents independently selected from the group consisting of Me, i<Pr, t<Bu, CN, CF3 and Ph, pyridinyl, which is optionally substituted with one or more substituents independently selected from the group consisting of Me, i<Pr, t<Bu, CN, CF3 and Ph, pyrimidinyl, which is optionally substituted with one or more substituents independently selected from the group consisting of Me, i<Pr, t<Bu, CN, CF3 and Ph, carbazolyl, which is optionally substituted with one or more substituents independently selected from the group consisting of Me, i<Pr, t<Bu, CN, CF3 and Ph, triazinyl, which is optionally substituted with one or more substituents independently selected from the group consisting of Me, i<Pr, t<Bu, CN, CF 3 and Ph, and N(Ph) 2 .

[0038] In a further embodiment of the invention, R b< is independently selected at each occurrence from the group consisting of H, Me, i< Pr, t< Bu, CN, CF 3 , Ph, which is optionally substituted with one or more substituents independently selected from the group consisting of Me, i< Pr, t< Bu, CN, CF 3 and Ph, pyridinyl, which is optionally substituted with one or more substituents independently selected from the group consisting of Me, i< Pr, t< Bu, CN, CF 3 and Ph, pyrimidinyl, which is optionally substituted with one or more substituents independently selected from the group consisting of Me, i< Pr, t< Bu, CN, CF 3 and Ph and triazinyl, which is optionally substituted with one or more substituents independently selected from the group consisting of Me, i< Pr, t< Bu, CN, CF 3 and Ph.

[0039] In a further embodiment of the invention, R b< is independently selected at each occurrence from the group consisting of H, CN, CF 3 .

[0040] In a further embodiment of the invention, R b< is independently selected at each occurrence from the group consisting of H and CN.

[0041] In an additional embodiment of the invention, the organic molecules of the invention comprise or consist of a structure selected from the group consisting of Formula Ilc-1, Formula Ilc-2, Formula Ilc-3, Formula Ilc-4 and Formula Ilc-5: where the definitions mentioned above apply.

[0042] In an additional embodiment of the invention, the organic molecules of the invention comprise or consist of a structure selected from the group consisting of Formula Ilc-1, Formula Ilc-2, and Formula Ilc-3:

[0043] In a further embodiment of the invention, the organic molecules according to the invention comprise or consist of a structure selected from the group consisting of formula Ilc-1, formula Ilc-2, formula Ilc-3, formula Ilc-4 and formula Ilc-5, wherein R b< at each occurrence is selected from the group consisting of H and CN.

[0044] In a further embodiment of the invention, the organic molecules according to the invention comprise or consist of a structure selected from the group consisting of formula Ilc-1, formula Ilc-2 and formula Ilc-3, wherein R b< at each occurrence is selected from the group consisting of H and CN.

[0045] In a further embodiment of the invention, the organic molecules according to the invention comprise or consist of a structure selected from the group consisting of formula IIc-1, formula IIc-2, formula IIc-3, formula IIc-4 and formula IIc-5, wherein R b< is H.

[0046] In a further embodiment of the invention, the organic molecules according to the invention comprise or consist of a structure selected from the group consisting of formula Ilc-1, formula Ilc-2 and formula Ilc-3, wherein R b< is H.

[0047] In a further embodiment of the invention, the organic molecules according to the invention comprise or consist of a structure selected from the group consisting of formula IIc-1, formula IIc-2, formula IIc-3, formula IIc-4 and formula IIc-5, wherein R b< is CN.

[0048] In a further embodiment of the invention, the organic molecules according to the invention comprise or consist of a structure selected from the group consisting of formula Ilc-1, formula Ilc-2 and formula Ilc-3, wherein R b< is CN.

[0049] In a preferred embodiment of the invention, the organic molecules according to the invention comprise or consist of a structure according to formula Ilc-1: where R b< at each occurrence is selected from the group consisting of H and CN.

[0050] In a preferred embodiment of the invention, the organic molecules according to the invention comprise or consist of the group shown below:

[0051] According to the invention, Ar EWG< is selected from the group consisting of

[0052] In a preferred embodiment of the invention, Ar EWG< is selected from the group consisting of

[0053] As used throughout this specification, the terms "aryl" and "aromatic" can be broadly understood to mean any mono-, bi-, or polycyclic aromatic moiety. Accordingly, an aryl group contains 6 to 60 aromatic ring atoms, and a heteroaryl group contains 5 to 60 aromatic ring atoms, at least one of which is a heteroatom. Nevertheless, throughout this specification, the number of aromatic ring atoms in the definition of certain substituents may be given as a subscript. In particular, the heteroaromatic ring contains one to three heteroatoms. The terms "heteroaryl" and "heteroaromatic" can be broadly understood to mean any mono-, bi-, or polycyclic heteroaromatic moiety containing at least one heteroatom.The heteroatoms may be the same or different at each occurrence and may be individually selected from the group consisting of N, O, and S. Accordingly, the term "arylene" refers to a divalent substituent that bears two bonding sites to other molecular structures and thus serves as a linking structure. If a group is defined differently in the exemplary embodiments than the definitions given herein, for example, if the number of aromatic ring atoms or the number of heteroatoms deviates from the given definition, the definition in the exemplary embodiments applies. According to the invention, a fused (annulated) aromatic or heteroaromatic polycycle consists of two or more individual aromatic or heteroaromatic cycles that have formed the polycycle through a condensation reaction.

[0054] In particular, as used throughout the specification, the term aryl group or heteroaryl group includes groups that can be attached via any position of the aromatic or heteroaromatic group derived from benzene, naphthalene, anthracene, phenanthrene, pyrene, dihydropyrene, chrysene, perylene, fluoranthene, benzanthracene, benzphenanthrene, tetracene, pentacene, benzopyrene, furan, benzofuran, isobenzofuran, dibenzofuran, thiophene, benzothiophene, isobenzothiophene, dibenzothiophene;Pyrrole, indole, isoindole, carbazole, pyridine, quinoline, isoquinoline, acridine, phenanthridine, benzo-5,6-quinoline, benzo-6,7-quinoline, benzo-7,8-quinoline, phenothiazine, phenoxazine, pyrazole, indazole, imidazole, benzimidazole, naphthoimidazole, phenanthroimidazole, pyridoimidazole, Pyrazinoimidazole, Quinoxalinoimidazole, Oxazole, Benzoxazole, Napthooxazole, Anthroxazole, Phenanthroxazole, Isoxazole, 1,2-thiazole, 1,3-thiazole, Benzothiazole, Pyridazine, Benzopyridazine, Pyrimidine, Benzopyrimidine, 1,3,5-Triazine, Quinoxaline, Pyrazine, Phenazine, naphthyridine, carboline, benzocarboline, Phenanthroline, 1,2,3-triazole, 1,2,4-triazole, benzotriazole, 1,2,3-oxadiazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole, 1,2,3,4-tetrazine, purine, pteridine, indolizine and benzothiadiazole or combinations of the above-mentioned groups.;

[0055] As used throughout this specification, the term cyclic group can be understood in the broadest sense as mono-, bi- or polycyclic moieties.

[0056] As used throughout this specification, the term alkyl group can be broadly understood as any linear, branched or cyclic alkyl substituent. In particular, the term alkyl includes the substituents methyl (Me), ethyl (Et), n-propyl ("Pr), i-propyl (i<Pr), cyclopropyl, n-butyl ("Bu), i-butyl ('Bu), s-butyl (s<Bu), t-butyl (t<Bu), cyclobutyl, 2-methylbutyl, n-pentyl, s-pentyl, t-Pentyl, 2-Pentyl, Neopentyl, Cyclopentyl, n-Hexyl, s-Hexyl, t-Hexyl, 2-Hexyl, 3-Hexyl, Neohexyl, Cyclohexyl, 1-Methylcyclopentyl, 2-Methylpentyl, n-Heptyl, 2-Heptyl, 3-Heptyl, 4-Heptyl, Cycloheptyl, 1-methylcyclohexyl, n-Octyl, 2-Ethylhexyl, Cyclooctyl, 1-Bicyclo[2,2,2]octyl, 2-Bicyclo[2,2,2]-octyl, 2-(2,6-Dimethyl)octyl, 3-(3,7-Dimethyl)octyl, Adamantyl, 2,2,2-Trifluoroethyl, 1,1-Dimethyl-n-hex-1-yl, 1,1-Dimethyl-n-hept-1-yl, 1,1-Dimethyl-n-oct-1-yl, 1,1-Dimethyl-n-dec-1-yl, 1,1-Dimethyl-n-dodec-1-yl, 1,1-Dimethyl-n-tetradec-1-yl, 1,1-Dimethyl-n-hexadec-1-yl, 1,1-Dimethyl-n-octadec-1-yl, 1,1-Diethyl-n-hex-1-yl, 1,1-Diethyl-n-hept-1-yl, 1,1-Diethyl-n-oct-1-yl, 1,1-Diethyl-n-dec-1-yl, 1,1-Diethyl-n-dodec-1-yl, 1,1-Diethyl-n-tetradec-1-yl, 1,1-Diethyln-n-hexadec-1-yl, 1,1-Diethyl-n-octadec-1-yl, 1-(n-propyl)-cyclohex-1-yl, 1-(n-butyl)-cyclohex-1-yl, 1-(n-Hexyl)-cyclohex-1-yl, 1-(n-Octyl)-cyclohex-1-yl and 1-(n-Decyl)-cyclohex-1-yl.,

[0057] As used throughout this specification, the term alkenyl includes linear, branched, and cyclic alkenyl substituents. The term alkenyl group includes, by way of example, the substituents ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl, cyclooctenyl, or cyclooctadienyl.

[0058] As used throughout this specification, the term alkynyl includes linear, branched, and cyclic alkynyl substituents. The term alkynyl group includes, for example, ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl, or octynyl.

[0059] As used throughout this specification, the term alkoxy includes linear, branched, and cyclic alkoxy substituents. The term alkoxy group includes, by way of example, methoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy, t-butoxy, and 2-methylbutoxy.

[0060] As used throughout this specification, the term thioalkoxy includes linear, branched and cyclic thioalkoxy substituents in which the O of the exemplary alkoxy groups is replaced by S.

[0061] As used throughout the specification, the terms "halogen" and "halo" may be understood in the broadest sense to mean preferably fluorine, chlorine, bromine or iodine.

[0062] Whenever hydrogen is mentioned herein, it may be replaced by deuterium at any occurrence.

[0063] It should be understood that when a molecular fragment is described as being a substituent or otherwise attached to another component, its name may be written as if it were a fragment (e.g., naphthyl, dibenzofuryl) or as if it were the entire molecule (e.g., naphthalene, dibenzofuran). As used herein, these different ways of referring to a substituent or attached fragment are considered equivalent.

[0064] In one embodiment, the organic molecules according to the invention have an excited state lifetime of not more than 150 µs, not more than 100 µs, in particular not more than 50 µs, more preferably not more than 10 µs or not more than 7 µs in a film of poly(methyl methacrylate) (PMMA) with 10 wt.% of the organic molecule at room temperature.

[0065] In one embodiment of the invention, the organic molecules according to the invention are thermally activated delayed fluorescence (TADF) emitters which have an • E ST value, which corresponds to the energy difference between the first excited singlet state (S1) and the first excited triplet state (T1), of less than 5000 cm -1< , preferably less than 3000 cm -1< , more preferably less than 1500 cm -1< , even more preferably less than 1000 cm- 1< or even less than 500 cm- 1<.

[0066] In a further embodiment of the invention, the organic molecules according to the invention have an emission peak in the visible or near ultraviolet range, ie in the range of a wavelength of 380 to 800 nm, with a half-width of less than 0.50 eV, preferably less than 0.48 eV, more preferably less than 0.45 eV, even more preferably less than 0.43 eV or even less than 0.40 eV in a film of poly(methyl methacrylate) (PMMA) with 10 wt.% of the organic molecule at room temperature.

[0067] In a further embodiment of the invention, the organic molecules according to the invention have a "blue material index" (BMI), which is calculated by dividing the photoluminescence quantum yield (PLQY) in % by the ClEy color coordinate of the emitted light, of more than 150, in particular more than 200, preferably more than 250, more preferably more than 300 or even more than 500.

[0068] Orbital energies and excited state energies can be determined either by experimental methods or by calculations using quantum chemical techniques, in particular calculations based on density functional theory. The energy of the highest occupied molecular orbital E HOMO< is determined by methods known to those skilled in the art from cyclic voltammetry measurements with an accuracy of 0.1 eV. The energy of the lowest unoccupied molecular orbital E LUMO< is calculated as E HOMO< + E gap<, where E gap< is determined as follows: For host compounds, the offset of the emission spectrum of a film containing 10 wt% of the host in poly(methyl methacrylate) (PMMA) is used as E gap< unless otherwise stated. For emitter molecules, E gap< is determined as the energy at which the excitation and emission spectra of a film containing 10 wt% of the emitter in PMMA cross.

[0069] The energy of the first excited triplet state T1 is determined from the offset of the emission spectrum at low temperature, typically at 77 K. For host compounds where the first excited singlet state and the lowest triplet state are separated in energy by >0.4 eV, phosphorescence is usually visible in a steady-state spectrum in 2-Me-THF. The triplet energy can thus be determined as the offset of the phosphorescence spectrum. For TADF emitter molecules, the energy of the first excited triplet state T1 is determined from the offset of the delayed emission spectrum at 77 K, unless otherwise measured in a PMMA film containing 10 wt% of the emitter. For both host and emitter compounds, the energy of the first excited singlet state S1 is determined from the offset of the emission spectrum, unless otherwise measured in a PMMA film containing 10 wt% of the host or emitter compound.The offset of an emission spectrum is determined by calculating the intersection point of the tangent to the emission spectrum with the x-axis. The tangent to the emission spectrum is set at the side of the high-energy emission region, i.e., where the emission region increases by moving from high-energy values ​​to low-energy values, and at the point at half-maximum of the maximum intensity of the emission spectrum.

[0070] A further aspect of the invention relates to a process for preparing organic molecules according to the invention (with optional subsequent reaction) using a palladium-catalyzed cross-coupling reaction: R a< is at each occurrence independently selected from the group consisting of RA< hydrogen, deuterium, N(R 6< ) 2 , OR 6< , Si(R 6< ) 3 , B(OR 6< ) 2 , OSO 2 R 6< , CF 3 , CN, F, Br, I, C 1 -C 40 alkyl, which is optionally substituted with one or more substituents R 6< and wherein one or more non-adjacent CH 2 groups are optionally substituted by R 6< C=CR 6< , C· C, Si(R 6< ) 2 , Ge(R 6< ) 2 , Sn(R 6< ) 2 , C=O, C=S, C=Se, C=NR 6< , P(=O)(R 6< ), SO, SO 2 , NR 6< , O, S or CONR 6< ; C 1 -C 40 alkoxy which is optionally substituted with one or more substituents R 6< and wherein one or more non-adjacent CH 2 groups are optionally substituted by R 6< C=CR 6< , C•C, Si(R 6< ) 2 , Ge(R 6< ) 2 , Sn(R 6< ) 2 , C=O, C=S, C=Se, C=NR 6< , P(=O)(R 6< ), SO, SO 2 , NR 6< , O, S or CONR 6< ;C 1 -C 40 -thioalkoxy which is optionally substituted with one or more substituents R 6< and wherein one or more non-adjacent CH 2 groups are optionally substituted by R 6< C=CR 6< , C· C, Si(R 6< ) 2 , Ge(R 6< ) 2 , Sn(R 6< ) 2 , C=O, C=S, C=Se, C=NR 6< , P(=O)(R 6< ), SO, SO 2 , NR 6< , O, S or CONR 6< ; C 2 -C 40 alkenyl which is optionally substituted by one or more substituents R 6< and wherein one or more non-adjacent CH 2 groups are optionally substituted by R 6< C=CR 6< , C· C, Si(R 6< ) 2 , Ge(R 6< ) 2 , Sn(R 6< ) 2 , C=O, C=S, C=Se, C=NR 6< , P(=O)(R 6< ), SO, SO 2 , NR 6< , O, S or CONR 6< ; C 2 -C 40 alkynyl which is optionally substituted with one or more substituents R 6< and wherein one or more non-adjacent CH 2 groups are optionally substituted by R 6<, C=CR 6<, C, C, Si(R 6<) 2, Ge(R 6<) 2, Sn(R 6<) 2, C=O, C=S, C=Se, C=NR 6<, P(=O)(R 6<), SO, SO 2, NR 6<, O, S or CONR 6<;C 6 -C 60 aryl which is optionally substituted with one or more substituents R 6< ; and C 3 -C 57 heteroaryl which is optionally substituted with one or more substituents R 6< . ;

[0071] According to the invention, E2, an Ar EWG< group substituted by the coupling group CG 1<, reacts with E3, a phenyl substituted by X, the coupling group CG 2<, and one F. The coupling groups CG 1< and CG 2< are selected as a reaction pair such that the Ar EWG< group of E2 is introduced at the substitution position CG 2< of E3. Preference is given to a so-called Suzuki coupling. Here, either CG 1< is selected from Cl, Br, or I and CG 2< is selected from a boronic acid or a boronic ester, in particular a boronic acid pinacol ester, or analogously, CG 2< is selected from Cl, Br, or I and CG 1< is selected from a boronic acid or a boronic ester, in particular a boronic acid pinacol ester.

[0072] DH can be prepared according to the following synthesis routes and The boronic acid ester can also be replaced by a boronic acid.

[0073] Typically, Pd 2 (dba) 3 (tris(dibenzylideneacetone)dipalladium(0)) is used as the palladium catalyst, but alternatives are known to those skilled in the art. For example, the ligand is selected from S-Phos ([2-dicyclohexylphosphino-2',6'-dimethoxy-1,T'-biphenyl]; or SPhos), XPhos (2-(dicyclohexylphosphino)-2",4",6"-triisopropylbiphenyl or XPhos), and P(Cy)s (tricyclohexylphosphine). The salt is for example selected from potassium phosphate, potassium carbonate, and potassium acetate, and the solvent can be either a pure solvent such as toluene or dioxane or a mixture such as toluene / dioxane / water. The skilled person will know which Pd catalyst, ligand, salt, and solvent combination is most likely to lead to high yields.

[0074] For the reaction of a nitrogen heterocycle in a nucleophilic aromatic substitution with an aryl halide, preferably an aryl fluoride, typical conditions involve the use of a base such as tribasic potassium phosphate or sodium hydride, for example in an aprotic polar solvent such as, for example, dimethyl sulfoxide (DMSO) or N,N-dimethylformamide (DMF).

[0075] An alternative synthetic route involves the introduction of a nitrogen heterocycle via copper- or palladium-catalyzed coupling to an aryl halide or aryl pseudohalide, preferably an aryl bromide, an aryl iodide, aryl triflate or an aryl tosylate.

[0076] A further aspect of the invention relates to the use of an organic molecule according to the invention as a luminescence emitter or as an absorber and / or as a host material and / or as an electron transport material and / or as a hole injection material and / or as a hole blocking material in an optoelectronic device.

[0077] An organic electroluminescent device can be broadly understood as any device based on organic materials that is capable of emitting light in the visible or near-ultraviolet (UV) range, i.e., in the wavelength range from 380 to 800 nm. More preferably, the organic electroluminescent device can be capable of emitting light in the visible range, i.e., from 400 to 800 nm.

[0078] In connection with such a use, the organic optoelectronic device is in particular selected from the group consisting of: organic light-emitting diodes (OLEDs), light-emitting electrochemical cells, OLED sensors, particularly in gas and vapor sensors that are not hermetically sealed to the outside, organic diodes, organic solar cells, organic transistors, organic field-effect transistors, organic lasers and down-conversion elements.

[0079] In a preferred embodiment in connection with such a use, the organic electroluminescent device is a device selected from the group consisting of an organic light-emitting diode (OLED), a light-emitting electrochemical cell (LEC) and a light-emitting transistor.

[0080] When used, the proportion of the organic molecule according to the invention in the emission layer in an optoelectronic device, in particular in OLEDs, is 1 wt.% to 99 wt.%, in particular 5 wt.% to 80 wt.%. In an alternative embodiment, the amount of the organic molecule in the emission layer is 100 wt.%.

[0081] In one embodiment, the light-emitting layer comprises not only the organic molecules according to the invention, but also a host material whose triplet (T1) and singlet (S1) energy levels are energetically higher than the triplet (T1) and singlet (S1) energy levels of the organic molecule.

[0082] A further aspect of the invention relates to a composition comprising or consisting of: (a) at least one organic molecule according to the invention, in particular in the form of an emitter and / or a host, and (b) one or more emitter and / or host materials which differ from the organic molecule according to the invention, and (c) optionally one or more dyes and / or one or more solvents.

[0083] In one embodiment, the light-emitting layer comprises (or consists (essentially) of) a composition comprising or consisting of: (a) at least one organic molecule according to the invention, in particular in the form of an emitter and / or a host, and (b) one or more emitter and / or host materials which differ from the organic molecule according to the invention, and (c) optionally one or more dyes and / or one or more solvents.

[0084] More preferably, the light-emitting layer EML comprises (or consists (essentially) of) a composition comprising or consisting of: (i) 1-50 wt.%, preferably 5-40 wt.%, in particular 10-30 wt.% of one or more organic molecules according to the invention; (ii) 5-99 wt.%, preferably 30-94.9 wt.%, in particular 40-89 wt.% of the at least one host compound H; and (iii) optionally 0-94 wt.%, preferably 0.1-65 wt.%, in particular 1-50 wt.% of the at least one further host compound D having a structure that deviates from the structure of the molecules according to the invention; and (iv) optionally 0-94 wt.%, preferably 0-65 wt.%, in particular 0-50 wt.% of a solvent; and (v) optionally 0-30 wt.%, in particular 0-20 wt.%, preferably 0-5 wt.% of at least one further emitter molecule F having a structure that deviates from the structure of the molecules according to the invention.

[0085] Preferably, energy can be transferred from the host compound H to one or more organic molecules according to the invention, in particular from the first excited triplet state T1(H) of the host compound H to the first excited triplet state T1(E) of the one or more organic molecules according to the invention and / or from the first excited singlet state S1(H) of the host compound H to the first excited singlet state S1(E) of the one or more organic molecules according to the invention.

[0086] In a further embodiment, the light-emitting layer EML comprises (or consists (essentially) of) a composition comprising or consisting of: (i) 1-50 wt.%, preferably 5-40 wt.%, in particular 10-30 wt.% of an organic molecule according to the invention; (ii) 5-99 wt.%, preferably 30-94.9 wt.%, in particular 40-89 wt.% of a host compound H; and (iii) optionally 0-94 wt.%, preferably 0.1-65 wt.%, in particular 1-50 wt.% of the at least one further host compound D having a structure that differs from the structure of the molecules according to the invention; and (iv) optionally 0-94 wt.%, preferably 0-65 wt.%, in particular 0-50 wt.% of a solvent; and (v) optionally 0-30 wt.%, in particular 0-20 wt.%, preferably 0-5 wt.% of at least one further emitter molecule F having a structure that differs from the structure of the molecules according to the invention.

[0087] In one embodiment, the host compound H has a highest occupied molecular orbital HOMO(H) with an energy E HOMO< (H) in the range of -5 to -6.5 eV, and the at least one further host compound D has a highest occupied molecular orbital HOMO(D) with an energy E HOMO< (D), where E HOMO< (H) > E HOMO< (D).

[0088] In a further embodiment, the host compound H has a lowest unoccupied molecular orbital LUMO(H) with an energy E LUMO< (H), and the at least one further host compound D has a lowest unoccupied molecular orbital LUMO(D) with an energy E LUMO< (D), where E LUMO< (H) > E LUMO< (D).

[0089] In one embodiment, the host compound H has a highest occupied molecular orbital HOMO(H) with an energy E HOMO< (H) and a lowest unoccupied molecular orbital LUMO(H) with an energy E LUMO< (H), and the at least one further host compound D has a highest occupied molecular orbital HOMO(D) with an energy E HOMO< (D) and a lowest unoccupied molecular orbital LUMO(D) with an energy E LUMO< (D), the organic molecule according to the invention has a highest occupied molecular orbital HOMO(E) with an energy E HOMO< (E) and a lowest unoccupied molecular orbital LUMO(E) with an energy E LUMO< (E), where E HOMO< (H) > E HOMO< (D) and the difference between the energy level of the highest occupied molecular orbital HOMO(E) of the organic molecule according to the invention (E HOMO< (E)) and the energy level of the highest occupied molecular orbital HOMO(H) of the host compound H (E HOMO< (H)) is between -0.5 eV and 0.5 eV, more preferably between -0.3 eV and 0.3 eV, even more preferably between -0.2 eV and 0.2 eV or even between -0.1 eV and 0.1 eV; and E LUMO< (H) > E LUMO< (D) and the difference between the energy level of the lowest unoccupied molecular orbital LUMO(E) of the organic molecule according to the invention (E LUMO< (E)) and the lowest unoccupied molecular orbital LUMO(D) of the at least one further host compound D (E LUMO< (D)) is between -0.5 eV and 0.5 eV, more preferably between -0.3 eV and 0.3 eV, even more preferably between -0.2 eV and 0.2 eV or even between -0.1 eV and 0.1 eV.

[0090] In a further aspect, the invention relates to an organic optoelectronic device comprising an organic molecule or composition of the type described here, in particular in the form of a device selected from the group consisting of organic light-emitting diode (OLED), light-emitting electrochemical cell, OLED sensor, in particular gas and vapor sensors that are not hermetically shielded from the outside, organic diode, organic solar cell, organic transistor, organic field-effect transistor, organic laser and down-conversion element.

[0091] In a preferred embodiment, the organic electroluminescent device is a device selected from the group consisting of an organic light-emitting diode (OLED), a light-emitting electrochemical cell (LEC), and a light-emitting transistor.

[0092] In one embodiment of the optoelectronic device according to the invention, the organic molecule according to the invention is used as emission material in a light-emitting layer EML.

[0093] In one embodiment of the optoelectronic device according to the invention, the light-emitting layer EML consists of the composition according to the invention described here.

[0094] If the organic electroluminescent device is an OLED, it may have the following layer structure as an example: 1. Substrate 2. Anode layer A 3. Hole injection layer, HIL 4. Hole transport layer, HTL 5. Electron blocking layer, EBL 6. Emitting layer, EML 7. Hole blocking layer, HBL 8. Electron transport layer, ETL 9. Electron injection layer, EIL 10. Cathode layer, wherein the OLED comprises each layer only optionally, different layers can be combined, and the OLED can comprise more than one layer of each layer type defined above.

[0095] In addition, the organic electroluminescent device may optionally comprise one or more protective layers that protect the device from damaging exposure to harmful environmental factors, including, for example, moisture, vapor and / or gases.

[0096] In one embodiment of the invention, the organic electroluminescent device is an OLED having the following inverted layer structure: 1. Substrate 2. Cathode layer 3. Electron injection layer, EIL 4. Electron transport layer, ETL 5. Hole blocking layer, HBL 6. Emitting layer, B 7. Electron blocking layer, EBL 8. Hole transport layer, HTL 9. Hole injection layer, HIL 10. Anode layer A wherein the OLED having a reversed layer structure comprises each layer only optionally, different layers can be merged, and the OLED can comprise more than one layer of each layer type defined above.

[0097] In one embodiment of the invention, the organic electroluminescent device is an OLED, which may have a stacked architecture. In this architecture, the individual units are stacked on top of each other, as opposed to the typical arrangement where the OLEDs are positioned side by side. Mixed light can be generated with OLEDs having a stacked architecture; in particular, white light can be generated by stacked blue, green, and red OLEDs. Furthermore, the OLED having a stacked architecture can optionally comprise a charge generation layer (CGL), which is typically positioned between two OLED subunits and typically consists of an n-doped and p-doped layer, with the n-doped layer of a CGL typically positioned closer to the anode layer.

[0098] In one embodiment of the invention, the organic electroluminescent device is an OLED comprising two or more emission layers between the anode and cathode. In particular, this so-called tandem OLED comprises three emission layers, with one emission layer emitting red light, one emission layer emitting green light, and one emission layer emitting blue light, and can optionally comprise further layers, such as charge generation layers, blocking or transport layers between the individual emission layers. In a further embodiment, the emission layers are stacked adjacently. In a further embodiment, the tandem OLED comprises a charge generation layer between every two emission layers. In addition, adjacent emission layers or emission layers separated by a charge generation layer can be merged.

[0099] The substrate can be formed by any material or composition of materials. Glass slides are most commonly used as substrates. Alternatively, thin metal layers (e.g., copper, gold, silver, or aluminum foils) or plastic films or slides can be used. This can allow for a greater degree of flexibility. The anode layer A is most often made of materials that allow for a (substantially) transparent film. Since at least one of the two electrodes should be (substantially) transparent to enable light emission from the OLED, either the anode layer A or the cathode layer C is transparent. Preferably, the anode layer A comprises a high content of, or even consists of, transparent conducting oxides (TCOs).Such an anode layer A may, for example, comprise indium tin oxide, aluminum zinc oxide, fluorine-doped tin oxide, indium zinc oxide, PbO, SnO, zirconium oxides, molybdenum oxide, vanadium oxide, tungsten oxide, graphite, doped Si, doped Ge, doped GaAs, doped polyaniline, doped polypyrrole and / or doped polythiophene.

[0100] More preferably, the anode layer A consists (essentially) of indium tin oxide (ITO) (e.g., (InO3)0.9(SnO2)0.1). The roughness of the anode layer A caused by the transparent conducting oxides (TCOs) can be compensated by using a hole injection layer (HIL). Furthermore, the HIL can facilitate the injection of quasi-carriers (e.g., holes), into which the transport of quasi-carriers from the TCO to the hole transport layer (HTL) is facilitated. The hole injection layer (HIL) can comprise poly-3,4-ethylenedioxythiophene (PEDOT), polystyrenesulfonate (PSS), MoO2, V2O3, CuPC, or CuI, in particular a mixture of PEDOT and PSS. The hole injection layer (HIL) can also prevent the diffusion of metal from the anode layer A into the hole transport layer (HTL).The HIL can be, for example, PEDOT:PSS (poly-3,4-ethylenedioxythiophene: polystyrenesulfonate), PEDOT (poly-3,4-ethylenedioxythiophene), mMTDATA (4,4;4'-tris[phenyl(m-tolyl)amino]triphenylamine), Spiro-TAD (2,2;7,7'-tetrakis(n,n-diphenylamino)-9,9'-spirobifluorene), DNTPD (N1,N1'-(biphenyl-4,4'-diyl)bis(N1-phenyl-N4,N4-di-m-tolylbenzene-1,4-diamine), NPB (N,N'-Nis-(1-naphthalenyl)-N,N'-bis-phenyl-(1,1'-biphenyl)-4,4'-diamine), NPNPB (N,N'-diphenyl-N,N'-di-[4-(N,N-diphenyl-amino)phenyl]benzidine), MeO-TPD (N,N,N•,N•-tetrakis(4-methoxyphenyl)benzidine), HAT-CN (1,4,5,8,9,11-hexaazatriphenylene-hexacarbonitrile) and / or spiro-NPD (N,N'-diphenyl-N,N'-bis-(1-naphthyl)-9,9'spirobifluorene-2,7-diamine).

[0101] Adjacent to the anode layer A or the hole injection layer (HIL) is typically a hole transport layer (HTL). Any hole transport compound can be used here. For example, electron-rich heteroaromatic compounds such as triarylamines and / or carbazoles can be used as hole transport compounds. The HTL can reduce the energy barrier between the anode layer A and the light-emitting layer EML. The hole transport layer (HTL) can also be an electron blocking layer (EBL). Preferably, the hole transport compound carries high energy levels of its triplet states T1.By way of example, the hole transport layer (HTL) may comprise a star-shaped heterocycle, such as tris(4-carbazoyl-9-ylphenyl)amine (TCTA), poly-TPD (poly(4-butylphenyldiphenylamine)), [alpha]-NPD (poly(4-butylphenyldiphenylamine)), TAPC (4,4'cyclohexylidene-bis[N,N-bis(4-methylphenyl)benzenamine]), 2-TNATA (4,4;4'tris[2-naphthyl(phenyl)amino]triphenylamine), spiro-TAD, DNTPD, NPB, NPNPB, MeO-TPD, HAT-CN and / or TrisPcz (9,9'-diphenyl-6-(9-phenyl-9H-carbazol-3-yl)-9H,9'H-3,3'-bicarbazole). Additionally, the HTL can comprise a p-doped layer consisting of an inorganic or organic dopant in an organic hole-transport matrix. Transition metal oxides, such as vanadium oxide, molybdenum oxide, or tungsten oxide, can be used as inorganic dopant, for example. Tetrafluorotetracyanoquinodimethane (F4-TCNQ), copper pentafluorobenzoate (Cu(I)pFBz), or transition metal complexes can be used as organic dopant, for example.

[0102] The EBL may, for example, comprise mCP (1,3-bis(carbazol-9-yl)benzene), TCTA, 2-TNATA, mCBP (3,3-di(9H-carbazol-9-yl)biphenyl), Tris-Pcz, CzSi (9-(4-tert-butylphenyl)-3,6-bis(triphenylsilyl)-9H-carbazole) and / or DCB (N,N-dicarbazolyl-1,4-dimethylbenzene).

[0103] Adjacent to the hole transport layer (HTL) is typically the light-emitting layer (EML). The light-emitting layer (EML) comprises at least one light-emitting molecule. In particular, the EML comprises at least one light-emitting molecule according to the invention. In one embodiment, the light-emitting layer comprises only the organic molecules according to the invention. Typically, the EML additionally comprises one or more host materials.By way of example, the host material is selected from CBP (4,4'-bis-(N-carbazolyl)-biphenyl), mCP, mCBP Sif87 (dibenzo[b,d]thiophen-2-yltriphenylsilane), CzSi, Sif88 (dibenzo[b,d]thiophen-2-yl)diphenylsilane), DPEPO (bis[2-(diphenylphosphino)phenyl]ether oxide), 9-[3-(Dibenzofuran-2-yl)phenyl]-9H-carbazole, 9-[3-(Dibenzofuran-2-yl)phenyl]-9H-carbazole, 9-[3-(Dibenzothiophen-2-yl)phenyl]-9H-carbazole, 9-[3,5-Bis(2-dibenzofuranyl)phenyl]-9H-carbazole, 9-[3,5-Bis(2-dibenzothiophenyl)phenyl]-9H-carbazole, T2T (2,4,6-tris(biphenyl-3-yl)-1,3,5-triazine), T3T (2,4,6-tris(triphenyl-3-yl)-1,3,5-triazine), and / or TST (2,4,6-tris(9,9-spirobifluoren-2-yl)-1,3,5-triazine). The host material should typically be selected to have first triplet (T1) and first singlet (S1) energy levels that are higher in energy than the first triplet (T1) and first singlet (S1) energy levels of the organic molecule.

[0104] In one embodiment of the invention, the EML comprises a so-called mixed host system with at least one hole-dominant host and one electron-dominant host. In a particular embodiment, the EML comprises precisely one light-emitting molecule according to the invention and a mixed host system comprising T2T as the electron-dominant host and a host selected from CBP, mCP, mCBP, 9-[3-(dibenzofuran-2-yl)phenyl]-9H-carbazole, 9-[3-(dibenzofuran-2-yl)phenyl]-9H-carbazole, 9-[3-(dibenzothiophen-2-yl)phenyl]-9H-carbazole, 9-[3,5-bis(2-dibenzofuranyl)phenyl]-9H-carbazole, and 9-[3,5-bis(2-dibenzothiophenyl)phenyl]-9H-carbazole as the hole-dominant host. In a further embodiment, the EML comprises 50-80 wt.%, preferably 60-75 wt.-% of a host selected from CBP, mCP, mCBP, 9-[3-(dibenzofuran-2-yl)phenyl]-9H-carbazole, 9-[3-(dibenzofuran-2-yl)phenyl]-9H-carbazole, 9-[3-(dibenzothiophen-2-yl)phenyl]-9H-carbazole, 9-[3,5-bis(2-dibenzofuranyl)phenyl]-9H-carbazole and 9-[3,5-bis(2-dibenzothiophenyl)phenyl]-9H-carbazole; 10-45 wt.%, preferably 15-30 wt.% of T2T and 5-40 wt.%, preferably 10-30 wt.% of the light-emitting molecule according to the invention.

[0105] An electron transport layer (ETL) can be located adjacent to the light-emitting layer (EML). Any electron carrier can be used here. Examples include compounds with few electrons, such as benzimidazoles, pyridines, triazoles, oxadiazoles (e.g., 1,3,4-oxadiazole), phosphine oxides, and sulfones. An electron transporter can also be a star-shaped heterocycle, such as 1,3,5-tri(1-phenyl-1H-benzo[d]imidazol-2-yl)phenyl (TPBi). The ETL may include NBphen (2,9-bis(naphthalen-2-yl)-4,7-diphenyl-1,10-phenanthroline), Alq3 (aluminum tris(8-hydroxyquinoline)), TSPO1 (diphenyl-4-triphenylsilylphenyl phosphine oxide), BPyTP2 (2,7-di(2,2-bipyridin-5-yl)triphenyl), Sif87 (dibenzo[b,d]thiophen-2-yltriphenylsilane), Sif88 (dibenzo[b,d]thiophen-2-yl)diphenylsilane), BmPyPhB (1,3-bis[3,5-di(pyridin-3-yl)phenyl]benzene) and / or BTB (4,4'bis-[2-(4,6-diphenyl-1,3,5-triazinyl)]-1,1-biphenyl).Optionally, the ETL can be doped with materials such as Liq. The electron transport layer (ETL) can also block holes, or a hole-blocking layer (HBL) can be introduced.

[0106] The HBL can be, for example, BCP (2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline = bathocuproin), BAlq (bis(8-hydroxy-2-methylquinoline)-(4-phenylphenoxy)aluminum), NBphen (2,9-bis(naphthalen-2-yl)-4,7-diphenyl-1,10-phenanthroline), Alq3 (aluminum tris(8-hydroxyquinoline)), TSPO1 (diphenyl-4-triphenylsilylphenyl phosphine oxide), T2T (2,4,6-tris(biphenyl-3-yl)-1,3,5-triazine), T3T (2,4,6-tris(triphenyl-3-yl)-1,3,5-triazine), TST (2,4,6-Tris(9,9'spirobifluoren-2-yl)-1,3,5-triazine) and / or TCB / TCP (1,3,5-Tris(N-carbazolyl)benzene / 1,3,5-Tris(carbazol)-9-yl)benzene).

[0107] A cathode layer C can be located adjacent to the electron transport layer (ETL). For example, the cathode layer C can comprise or consist of a metal (e.g., Al, Au, Ag, Pt, Cu, Zn, Ni, Fe, Pb, LiF, Ca, Ba, Mg, In, W, or Pd) or a metal alloy. For practical reasons, the cathode layer can also consist of (essentially) non-transparent metals, such as Mg, Ca, or Al. Alternatively or additionally, the cathode layer C can also comprise graphite and / or carbon nanotubes (CNTs). Alternatively, the cathode layer C can also consist of nanoscale silver wires.

[0108] An OLED may further optionally comprise a protective layer between the electron transport layer (ETL) and the cathode layer (which may be referred to as the electron injection layer (EIL). This layer may comprise lithium fluoride, cesium fluoride, silver, Liq (8-hydroxyquinolinolatolithium), LiZO, BaF2, MgO, and / or NaF.

[0109] Optionally, the electron transport layer (ETL) and / or a hole blocking layer (HBL) may also comprise one or more host compounds.

[0110] To further modify the emission spectrum and / or the absorption spectrum of the light-emitting layer EML, the light-emitting layer EML may further comprise one or more additional emitter molecules F. Such an emitter molecule F may be any emitter molecule known in the art. Preferably, such an emitter molecule F is a molecule with a structure that deviates from the structure of the molecules according to the invention. The emitter molecule F may optionally be a TADF emitter. Alternatively, the emitter molecule F may optionally be a fluorescent and / or phosphorescent emitter molecule capable of changing the emission spectrum and / or the absorption spectrum of the light-emitting layer EML.For example, triplet and / or singlet excitons can be transferred from the emitter molecule according to the invention to the emitter molecule F before it relaxes to the initial state S0, typically by red-shifting light compared to the light emitted by the emitter molecule E. Optionally, the emitter molecule F can also induce two-photon effects (i.e., the absorption of two photons with half the energy of the absorption maximum).

[0111] Optionally, an organic electroluminescent device (e.g., an OLED) may, for example, be a substantially white organic electroluminescent device. For example, such a white organic electroluminescent device may comprise at least one (dark) blue emitter molecule and one or more emitter molecules that emit green and / or red light. Then, optionally, energy transfer between two or more molecules may also occur, as described above.

[0112] As used herein, unless more specifically defined in a particular context, the designation of the colors of emitted and / or absorbed light is as follows: violet: Wavelength range of >380-420 nm; dark blue: Wavelength range of >420-480 nm; sky blue: Wavelength range of >480-500 nm; green: Wavelength range of >500-560 nm; yellow: Wavelength range of >560-580 nm; orange: Wavelength range of >580-620 nm; red: Wavelength range of >620-800 nm.

[0113] With respect to emitter molecules, such colors refer to the emission maximum. Therefore, for example, a dark blue emitter has an emission maximum in the range of >420 to 480 nm, a sky blue emitter has an emission maximum in the range of >480 to 500 nm, a green emitter has an emission maximum in a range of >500 to 560 nm, and a red emitter has an emission maximum in a range of >620 to 800 nm.

[0114] A dark blue emitter can preferably have an emission maximum of below 480 nm, more preferably below 470 nm, even more preferably below 465 nm, or even below 460 nm. It is typically more than 420 nm, preferably more than 430 nm, more preferably more than 440 nm, or even more than 450 nm.

[0115] Accordingly, a further aspect of the present invention relates to an OLED which has an external quantum efficiency at 1000 cd / m 2< of more than 8%, more preferably of more than 10%, more preferably of more than 13%, even more preferably of more than 15% or even more than 20% and / or an emission maximum between 420 nm and 500 nm, preferably between 430 nm and 490 nm, more preferably between 440 nm and 480 nm, even more preferably between 450 nm and 470 nm and / or an LT80 value at 500 cd / m 2< of more than 100 h, preferably more than 200 h, more preferably more than 400 h, even more preferably more than 750 h or even more than 1000 h. Accordingly, a further aspect of the present invention relates to an OLED whose emission has a ClEy color coordinate of less than 0.45, preferably less than 0.30, more preferably less than 0.20, or even more preferably less than 0.15 or even less than 0.10.

[0116] Another aspect of the present invention relates to an OLED that emits light at a different color point. According to the present invention, the OLED emits light with a narrow emission range (small full width at half maximum (FWHM)). In one aspect, the OLED according to the invention emits light with a FWHM of the main emission peak of less than 0.50 eV, preferably less than 0.48 eV, more preferably less than 0.45 eV, even more preferably less than 0.43 eV, or less than 0.40 eV.

[0117] Another aspect of the present invention relates to an OLED that emits light with ClEx and ClEy color coordinates close to the ClEx (= 0.131) and ClEy (= 0.046) color coordinates of the primary color blue (ClEx = 0.131 and ClEy = 0.046), as defined by ITU-R Recommendation BT.2020 (Rec. 2020), and is thus suitable for use in ultra-high-definition (UHD) displays, e.g., UHD TVs. Conventional applications typically use top-emitting (top electrode is transparent) devices, whereas test devices used throughout the description represent bottom-emitting devices (bottom electrode and substrate are transparent). The ClEy color coordinate of a blue device can be reduced by up to a factor of two when switching from a bottom-emitting to a top-emitting device, while the ClEx remains almost unchanged (Okinaka et al. (2015), 22.1: Invited Paper: New Fluorescent Blue Host Materials for Achieving Low Voltage in OLEDs, SID Symposium Digest of Technical Papers, 46; doi:10.1002 / sdtp.10480). Accordingly, a further aspect of the present invention relates to an OLED whose emission has a CIEx color coordinate of between 0.02 and 0.30, preferably between 0.03 and 0.25, more preferably between 0.05 and 0.20 or more preferably between 0.08 and 0.18 or even between 0.10 and 0.15 and / or a CIEy color coordinate of between 0.00 and 0.45, preferably between 0.01 and 0.30, more preferably between 0.02 and 0.20 or even more preferably between 0.03 and 0.15 or even between 0.04 and 0.10.

[0118] In a further aspect, the invention relates to a method for producing an optoelectronic component. In this case, an organic molecule of the invention is used.

[0119] The organic electroluminescent device, in particular the OLED according to the present invention, can be produced by means of vapor deposition and / or liquid treatment. Accordingly, at least one layer manufactured using a sublimation process, manufactured using an organic vapor deposition process, manufactured using a carrier gas sublimation process, solution processed, or printed.

[0120] The methods used to fabricate the organic electroluminescent device, in particular the OLED according to the present invention, are known in the art. The various layers are deposited individually and sequentially on a suitable substrate using a subsequent deposition process. The individual layers can be deposited using the same or different deposition methods.

[0121] Examples of vapor deposition processes include thermal (co-)evaporation, chemical vapor deposition, and physical vapor deposition. For an active matrix OLED display, an AMOLED backplane is used as a substrate. The single layer can be processed from solutions or dispersions using appropriate solvents. The solution deposition process includes, for example, spin coating, dip coating, and spray printing. Liquid treatment can optionally be performed in an inert atmosphere (e.g., a nitrogen atmosphere), and the solvent can optionally be completely or partially removed using means known in the art. Examples General synthesis scheme I

[0122] General process for the synthesis AA V0:

[0123]

[0124] E0 (1.20 equivalents), 6-RB< -substituted 3-bromocarbazole (1.00 equivalent), Pd 2 (dba) 3 (0.03 equivalent), 2-dicyclohexylphosphino-2;4',6-triisopropylbiphenyl (XPhos) (0.12 equivalents), and tribasic potassium phosphate (1.50 equivalents) are stirred under a nitrogen atmosphere in a toluene / water mixture (ratio of 10:1, 3 ml of toluene per mmol of aryl bromide) at 110 °C for 16 hours. The reaction mixture is then filtered, and the residue is washed with dichloromethane. The solvent is removed. The crude product obtained is purified by recrystallization or column chromatography and obtained as a solid. An appropriate boronic acid can be used instead of a boronic acid ester. General synthesis scheme II

[0125] General process for synthesis AA V1:

[0126]

[0127] X-substituted fluorophenylboronic acid pinacol ester E0-1(1.20 equivalents), 2-,4-di-R 1< -substituted-6-chloro-1,3,5-triazine E0-2 (1.00 equivalent), Pd 2 (dba) 3 (0.03 equivalent), tricyclohexylphosphine (PCys) (0.07 equivalent), and tribasic potassium phosphate (2.50 equivalents) are stirred under a nitrogen atmosphere in a dioxane / toluene / water mixture (ratio of 4:1:1, 4 ml of dioxane per mmol of triazine) at 110 °C for 16 hours. The reaction mixture is then filtered, and the residue is washed with dichloromethane. The solvent is removed. The crude product obtained is purified by recrystallization or column chromatography, and the product E1-II is obtained as a solid.

[0128] Instead of a boronic acid ester, a corresponding boronic acid can be used. General process for synthesis AA V2:

[0129]

[0130] E0-3 (1.00 equivalents) and E0-4(2.00 equivalents) is dissolved in dichloromethane and cooled in an ice bath. Antimony(V) chloride (1.00 equivalent) is added dropwise to the solution, the reaction mixture is stirred for one hour at room temperature and then stirred at 45 °C for 6 hours. The intermediate is filtered and washed with dichloromethane.

[0131] The dried solid is added to a cooled 25% ammonia solution (0-5 °C) and stirred overnight at room temperature. The reaction mixture is filtered, and the resulting solid is washed with water. The solid is added to DMF and stirred at 155 °C for 30 minutes. The precipitated solid is filtered while hot. Water is added to the hot DMF solution to precipitate the product. E1-II is obtained by filtration. General process for synthesis AA V3:

[0132]

[0133] E1-II (1.00 equivalents), the corresponding donor molecule DH (1.00 equivalent) and tribasic potassium phosphate (4.00 equivalent) are suspended in DMSO under a nitrogen atmosphere and stirred at 120 °C (16 h). The reaction mixture is then poured into a saturated sodium chloride solution and extracted three times with dichloromethane. The combined organic phases are washed twice with saturated sodium chloride solution, dried over MgSO4, and the solvent is removed. The crude product is purified by recrystallization or flash chromatography. The product is obtained as a solid.

[0134] Alternatively, AA V3 for example, halogen-substituted carbazole DH-Hal, in particular a 3-bromo-substituted carbazole, for example 3-bromocarbazole, can be used instead of DH.

[0135] In a subsequent reaction, a boronic acid ester group or a boronic acid group can be introduced, for example, at the position of the one or more halogen substituents introduced via DH-Hal, thus yielding the corresponding carbazol-3-ylboronic acid ester or the corresponding carbazol-3-boronic acid, for example by reaction with bis(pinacol)diboronic acid ester (CAS No. 73183-34-3). Subsequently, a substituent where the dashed line represents the binding site, instead of the boronic acid ester group or the boronic acid group via a coupling reaction with the corresponding halogenated reactant, preferably Alternatively, a substituent at the position of one halogen substituent, which is DH-Hal was introduced, via the reaction with a broronic acid of the substituent or a corresponding boronic acid ester.

[0136] Alternatively, the bromination of a carbozole derivative can be achieved in a reaction with N-bromosuccinimide as shown in the following reaction scheme: HPLC-MS:

[0137] HPLC-MS spectroscopy is performed on an Agilent HPLC (1100 series) with MS detector (Thermo LTQ XL).

[0138] For example, a 4.6 mm x 150 mm, 3.5 µm reversed-phase column from Agilent (ZORBAX Eclipse Plus 95Ä C18, 4.6 x 150 mm, 3.5 µm HPLC column) is used in the HPLC. The HPLC-MS measurements are performed at room temperature (RT) with the following gradients: flow rate using the following solvent mixtures: Solvent A: H2O (90%) MeCN (10%) Solvent B: H2O (10%) MeCN (90%) Solvent C: THF (50%) MeCN (50%)

[0139] For the measurements, an injection volume of 5 µl is taken from a solution with a concentration of 0.5 mg / ml.

[0140] The ionization of the sample is carried out by APCI (chemical ionization at atmospheric pressure) in either positive (APCI +) or negative (APCI -) ionization mode. Cyclic voltammetry

[0141] Cyclic voltammograms are measured using solutions with a concentration of 10 -3 < mol / L of the organic molecules in dichloromethane or a suitable solvent and a suitable supporting electrolyte (e.g., 0.1 mmol / L of tetrabutylammonium hexafluorophosphate). The measurements are performed at room temperature under a nitrogen atmosphere using a three-electrode assembly (working and counter electrodes: Pt wire, reference electrode: Pt wire) and calibrated using FeCp 2 / FeCp 2 +< as an internal standard. The HOMO data were corrected using ferrocene as an internal standard against a saturated calomel electrode (SCE). Calculation based on density functional theory

[0142] Molecular structures are optimized using the BP68 function and the identity resolution (RI) approach. Excitation energies are calculated using the BP68-optimized structures using time-dependent DFT (TD-DFT) structures. Orbital and excited-state energies are calculated using the B2LYP function. Def2-SVP initial sets and an m4 grid for numerical integration are used. The Turbomole program package is used for all calculations. Photophysical measurements

[0143] Sample pretreatment: Spin coating device: Spin150, SPS euro.

[0144] The sample concentration is 1 mg / ml, prepared in chloroform or dichloromethane. 9 mg of PMMA is added to 1 ml of the corresponding solution. The corresponding thin film is prepared using 50 µl of the resulting solution.

[0145] Program: 1) 3 s at 400 rpm; 2) 20 s at 1000 rpm; 3) 10 s at 4000 rpm. After coating, the films were dried in air for 1 min at 70 °C on an LHG precision hot plate.

[0146] Photoluminescence spectroscopy and TCSPC ( Time-correlated single-photon counting ) Stationary emission spectroscopy is carried out using a Horiba Scientific FluoroMax-4 fluorescence spectrometer equipped with a 150 W xenon-arc lamp, excitation and emission monochromators, a Hamamatsu R928 photomultiplier tube, and a time-correlated single-photon counting ( Time-correlated single-photon counting, TCSPC) option. The sample chamber was continuously purged with nitrogen (flow rate > 800 ml / min). Emission and excitation spectra were corrected using standard correction curves.

[0147] Emission decay times are determined using the same system using the TCSPC method with FM-2013 equipment and a Horiba Yvon TCSPC Hub.

[0148] Sources of inspiration: NanoLED 370 (wavelength: 371 nm, pulse duration: 1.1 ns) NanoLED 290 (wavelength: 294 nm, pulse duration: <1 ns) SpectraLED 310 (wavelength: 314 nm) SpectraLED 355 (wavelength: 355 nm).

[0149] The evaluation (exponential fitting) was performed using the software package DataStation and the DAS 6 evaluation software. The fit was specified using the chi-square method. c 2 = ∑ k = 1 i e i − o i 2 e i with ei : size predicted by the fit and oi : measured size. Time-resolved PL spectroscopy in the µs range

[0150] Time-resolved transients are also measured on an FS5 fluorescence spectrometer from Edinburgh Instruments. Compared to measurements on the comparable HORIBA system, the FS5 enables increased light yield and thus an improved ratio between sample emission and background noise, which particularly improves measurements of delayed fluorescent emitters. The sample to be examined is excited using a broadband xenon lamp (150 W xenon arc lamp). The FS5 uses Czerny-Turner monochromators for both selective excitation and emission wavelengths. The photoluminescence of the sample is detected using an R928P photomultiplier tube, with the detector's photocathode enabling time-resolved measurements in the spectral range from 200 nm to 870 nm. The temperature-stabilized detector unit also ensures a dark count rate of less than 300 events per second.To determine the decay time of the PL transient, the µs range is then approximated using three exponential functions. Amplitude weighting yields an average lifetime τ DF for the delayed fluorescence of . τ DF = ∑ i = 1 3 A i τ i A i , with the respective monoexponential decay times τ i and associated amplitudes A i . Measurements of photoluminescence quantum yield

[0151] The photoluminescence quantum yield (PLQY) was measured using an Absolute PL Quantum Yield Measurement C9920-03G system from Hamamatsu Photonics. This system consists of a 150 W xenon gas discharge lamp, automatically adjustable Czerny-Turner monochromators (250–950 nm), and an integrating sphere with a highly reflective Spektralon coating (a Teflon derivative). The sphere is connected via a fiber optic cable to a PMA-12 multichannel detector with a BT (back-thinned) CCD chip with 1024 x 122 pixels (size 24 x 24 µm). The evaluation of the quantum efficiency and the CIE coordinates was carried out using the software U6039-05 version 3.6.0. Emission maxima are given in nm, quantum yields Φ in % and CIE coordinates as x-, y-values.

[0152] PLQY is determined using the following protocol: 1) Quality assurance: Anthracene in ethanol with a known concentration served as the reference material. 2) Determination of the excitation wavelength: First, the absorption maximum of the organic molecule was determined and then excited with this wavelength. 3) Sample measurement: The absolute quantum yield was determined for degassed solutions and films under a nitrogen atmosphere.

[0153] The calculation was carried out internally according to the following equation: Φ PL = n photon , emittiert n photon , absorbed = ∫ λ hc Int emittiert Probe λ − Int emittiert Referenz λ dλ ∫ λ hc Int emittiert Referenz λ − Int absorbed Probe λ dλ where n photon is the photon count and Int. is the intensity. Fabrication and characterization of organic electroluminescent devices

[0154] OLED devices comprising organic molecules according to the invention can be fabricated using vacuum deposition techniques. If a layer contains more than one compound, the weight percentage of one or more compounds is given as a percentage. The total weight percentage values ​​are 100%; therefore, if a value is not given, the proportion of that compound is equal to the difference between the given values ​​and 100%.

[0155] The not fully optimized OLEDs are characterized using standard methods and by measuring electroluminescence spectra, the external quantum efficiency (in %) as a function of intensity, calculated using the light detected by the photodiode and the current. The lifetime of the OLED device is extracted from the change in luminance during operation at a constant current density. The LT50 value corresponds to the time at which the measured luminance drops to 50% of the initial luminance; similarly, LT80 corresponds to the time at which the measured luminance drops to 80% of the initial luminance; LT95 to the time at which the measured luminance drops to 95% of the initial luminance; and so on.

[0156] Accelerated lifetime measurements are performed (e.g., applying increased current densities). For example, LT80 values ​​at 500 cd / m 2 < are determined using the following equation: LT 80 500 cd 2 m 2 = LT 80 L 0 L 0 500 cd 2 m 2 1.6 where L 0 which characterizes the initial luminance at the applied current density.

[0157] The value corresponds to the average of several pixels (typically two to eight), with the standard deviation between these pixels given. The figures show the data series for one OLED pixel. Example 1

[0158] Example 1 was prepared according to

[0159] AAVO (74 % yield), where 3-bromocarbazole (CAS 1592-95-6) and was used as E0, AAV1 (83% yield), using 2-chloro-4,6-diphenyl-1,3,5-triazine (CAS 3842-55-5) as E0-2 and 2-fluoro-5-cyanophenylboronic acid pinacol ester as E0-1 was used and AA V3 (68% yield) was synthesized.

[0160] MS (HPLC-MS), m / z (retention time): 740.24 (11.71 min).

[0161] Figure 1 represents the emission spectrum of example 1 (10 wt.% in PMMA). The emission maximum is at 483 nm. The photoluminescence quantum yield (PLQY) is 82%, the half-width is 0.43 eV, and the emission decay time is 10 µs. Example 2

[0162]

[0163] Example 2 was in accordance with AAVO (74 % yield), where 3-bromocarbazole (CAS 1592-95-6) and was used as E0,

[0164] AA V2 (99% yield), using benzonitrile (CAS 100-47-0) as E0-4 and 2-fluorobenzoyl chloride was used as E0-3 and AA V3 (50% yield) synthesized.

[0165] MS (HPLC-MS), m / z (retention time): 714.23 (12.75 min).

[0166] Figure 2 represents the emission spectrum of example 2(10 wt.% in PMMA). The emission maximum is at 467 nm. The photoluminescence quantum yield (PLQY) is 75%, the half-width is 0.43 eV, and the emission decay time is 19 µs. Example 3

[0167] Example 3 was in accordance with

[0168] AA VO (27 % yield), where 3-bromocarbazole (CAS 1592-95-6) and as E0 was used,

[0169] AAV1 (83% yield), using 2-chloro-4,6-diphenyl-1,3,5-triazine (CAS 3842-55-5) as E0-2 and 2-Fluoro-5-Cyanophenylboronic acid pinacol ester as E0-1 was used and AA V3 (65% yield) was synthesized.

[0170] MS (HPLC-MS), m / z (retention time): 806.24 (12.43 min).

[0171] Figure 3represents the emission spectrum of Example 3 (10 wt.% in PMMA). The emission maximum is at 490 nm. The photoluminescence quantum yield (PLQY) is 74%, and the half-width is 0.44 eV. Example 4

[0172] Example 4 was prepared according to

[0173] AA VO (27 % yield), where 3-bromocarbazole (CAS 1592-95-6) and as E0 was used, AA V2 (99 % yield), using benzonitrile (CAS 100-47-0) as E0-4 and 2-fluorobenzoyl chloride as E0-3 and AA V3 (74% yield) was synthesized.

[0174] MS (HPLC-MS), m / z (retention time): 780.19 (17.13 min).

[0175] Figure 4 represents the emission spectrum of Example 4 (10 wt.% in PMMA). The emission maximum is at 473 nm. The photoluminescence quantum yield (PLQY) is 62%, the half-width is 0.45 eV, and the emission decay time is 43 µs. Example 5

[0176] Example 5 was prepared according to

[0177] AAV0 (62% yield), where 3-bromocarbazole (CAS 1592-95-6) and as E0 was used, AA V2 (99% yield), using benzonitrile (CAS 100-47-0) as E0-4 and 2-fluorobenzoyl chloride as E0-3 was used and AA V3 (31% yield) was synthesized.

[0178] MS (HPLC-MS), m / z (retention time): 716.36 (15.17 min).

[0179] Figure 5 represents the emission spectrum of Example 5 (10 wt.% in PMMA). The emission maximum is at 473 nm. The photoluminescence quantum yield (PLQY) is 77%, the half-width is 0.44 eV, and the emission decay time is 60 µs. Example 6

[0180] Example 6 was prepared according to

[0181] AAV1 (83% yield), using 2-chloro-4,6-diphenyl-1,3,5-triazine (CAS 3842-55-5) as E0-2 and 2-Fluoro-5-Cyanophenylboronic acid pinacol ester as E0-1 was used and analogous to AAV3 (81% yield), using 3-bromocarbazole (CAS 1592-95-6) as DH. The product from the reaction according to AA V3 : is then reacted with bis(pinacolato)diboron as follows: and then with according to implemented.

[0182] MS (HPLC-MS), m / z (retention time): 765.22 (11.07 min).

[0183] Figure 6 represents the emission spectrum of Example 6 (10 wt.% in PMMA). The emission maximum is at 473 nm. The photoluminescence quantum yield (PLQY) is 64%, the half-width is 0.43 eV, and the emission decay time is 15 µs. Example 7

[0184]

[0185] Example 7 was prepared according to AA V2 (99 % yield), using benzonitrile (CAS 100-47-0) as E0-4 and 2-fluorobenzoyl chloride as E0-3 was used, analogous to AA V3 (81% yield), using 3-bromocarbazole (CAS 1592-95-6) as DH. The product from the reaction according to AAV3: was then reacted with bis(pinacolato)diboron as follows: and then with 2-chloro-4,6-diphenyl-1,3,5-triazine (CAS 3842-55-5) according to which is then reacted with N-bromosuccinimide (CAS 128-08-5) according to (83% yield). The product from the reaction was prepared according to AAV0 (68% yield), where as E0 was used.

[0186] MS (HPLC-MS), m / z (retention time): 971.17 (15.43 min).

[0187] Figure 7represents the emission spectrum of Example 7 (10 wt.% in PMMA). The emission maximum is at 481 nm. The photoluminescence quantum yield (PLQY) is 69%, the half-width is 0.43 eV, and the emission decay time is 12 µs. Example 8

[0188] The emission maximum of Example 8 (10 wt.% in PMMA) is at 466 nm. Example 9

[0189]

[0190] The emission maximum of Example 9 (10 wt.% in PMMA) is at 480 nm. Examples D1

[0191] Example 1 was tested in OLED components D1 with the following structure (the proportion of the molecule according to the invention in the emission layer is given in mass percent): layer thickness D1 10 100 nm Al 9 2 nm Liq 8 20 nm NBPhen 7 10 nm MAT1 6 50 nm mCBP (70%): MAT1 (20%) : 1 (10%) 5 10 nm mCBP 4 10 nm TCTA 3 40 nm NPB 2 5 nm HAT-CN 1 50 nm ITO Substrat Glass

[0192] For device D1, an external quantum efficiency of 19.2% ± 0.7 was determined at 1000 cd / m 2 . The emission maximum is at 487 nm, ClEx was determined to be 0.32, and the CIEy was 0.17 at 5.9 V. Further examples of organic molecules according to the invention

[0193] Figures The figures show:

[0194] Figure 1 Emission spectrum of Example 1 (10 wt%) in PMMA. Figure 2 Emission spectrum of Example 2 (10 wt%) in PMMA. Figure 3 Emission spectrum of Example 3 (10 wt%) in PMMA. Figure 4 Emission spectrum of Example 4 (10 wt%) in PMMA. Figure 5 Emission spectrum of Example 5 (10 wt%) in PMMA. Figure 6 Emission spectrum of Example 6 (10 wt%) in PMMA. Figure 7 Emission spectrum of Example 7 (10 wt%) in PMMA.

Claims

1. Organic molecule selected from the group consisting of formula IIa-1, formula Ila-2 and formula Ila-3: wherein X is selected from the group consisting of H, SiMe3, SiPh3, CN and CF3; ArEWG is selected from the group consisting of formulae IIa to IIc and IIi wherein # represents the bonding site of a single bond connecting ArEWG to the phenyl ring; R1 is selected independently from each other at each occurrence from the group consisting of hydrogen, deuterium, C1-C5 alkyl, wherein one or more hydrogen atoms are optionally substituted by deuterium; C2-C8 alkenyl, wherein one or more hydrogen atoms are optionally substituted by deuterium; C2-C8 alkynyl, wherein one or more hydrogen atoms are optionally substituted by deuterium; and C6-C18 aryl, which is optionally substituted by one or more substituents R6; R2 is selected independently from each other at each occurrence from the group consisting of hydrogen, deuterium, C1-C5 alkyl, wherein one or more hydrogen atoms are optionally substituted by deuterium; C2-C8 alkenyl, wherein one or more hydrogen atoms are optionally substituted by deuterium; C2-C8 alkynyl, wherein one or more hydrogen atoms are optionally substituted by deuterium; and C6-C18 aryl, which is optionally substituted with one or more substituents R6; Rd is selected independently from each other at each occurrence from the group consisting of hydrogen, deuterium, N(R6)2, OR6, Si(R6)3, B(OR6)2, OSO2R6, CF3, CN, F, Br, I, C1-C40 alkyl, which is optionally substituted by one or more substituents R6 and wherein one or more non-adjacent CH2 groups are optionally substituted by R6C=CR6, C·C, Si(R6)2, Ge(R6)2, Sn(R6)2, C=O, C=S, C=Se, C=NR6, P(=O)(R6), SO, SO2, NR6, O, S or CONR6; C1-C40-alkoxy, which is optionally substituted by one or more substituents R6 and wherein one or more non-adjacent CH2 groups are optionally substituted by R6C=CR6, C•C, Si(R6)2, Ge(R6)2, Sn(R6)2, C=O, C=S, C=Se, C=NR6, P(=O)(R6), SO, SO2, NR6, O, S or CONR6; C1-C40-thioalkoxy, which is optionally substituted by one or more substituents R6 and wherein one or more non-adjacent CH2 groups are optionally substituted by R6C=CR6, C·C, Si(R6)2, Ge(R6)2, Sn(R6)2, C=O, C=S, C=Se, C=NR6, P(=O)(R6), SO, SO2, NR6, O, S or CONR6; C2-C40-alkenyl, which is optionally substituted by one or more substituents R6 and wherein one or more non-adjacent CH2 groups are optionally substituted by R6C=CR6, C·C, Si(R6)2, Ge(R6)2, Sn(R6)2, C=O, C=S, C=Se, C=NR6, P(=O)(R6), SO, SO2, NR6, O, S or CONR6; C2-C40-alkynyl, which is optionally substituted by one or more substituents R6 and wherein one or more non-adjacent CH2 groups are optionally substituted by R6C=CR6, C•C, Si(R6)2, Ge(R6)2, Sn(R6)2, C=O, C=S, C=Se, C=NR6, P(=O)(R6), SO, SO2, NR6, O, S or CONR6; C6-C60 aryl, which is optionally substituted by one or more substituents R6; and C3-C57 heteroaryl, which is optionally substituted by one or more substituents R6; R6 is selected independently from each other at each occurrence from the group consisting of hydrogen, deuterium, OPh, CF3, CN, F, C1-C5-alkyl, wherein optionally one or more hydrogen atoms are substituted independently from each other by deuterium, CN, CF3 or F; C1-C5-alkoxy, wherein optionally one or more hydrogen atoms are substituted independently from each other by deuterium, CN, CF3 or F; C1-C5-thioalkoxy, wherein optionally one or more hydrogen atoms are substituted independently from each other by deuterium, CN, CF3 or F; C2-C5-alkenyl, wherein optionally one or more hydrogen atoms are substituted independently from each other by deuterium, CN, CF3 or F; C2-C5-alkynyl, wherein optionally one or more hydrogen atoms are substituted independently from each other by deuterium, CN, CF3 or F; C6-C18-aryl, which is optionally substituted by one or more C1-C5-alkyl substituents; C3-C17-heteroaryl, which is optionally substituted by one or more C1-C5-alkyl substituents; N(C6-C18-aryl)2; N(C3-C17-heteroaryl)2, and N(C3-C17-heteroaryl)(C6-C18-aryl); RA is selected independently from each other at each occurrence from a chemical structure of formula IIA or a chemical structure of formula IIB wherein RN is selected from the group consisting of Me, iPr, tBu, CN, CF3 and Ph; wherein $ represents the binding site of a single bond; wherein RB is selected from the group consisting of H, Ph, CN, CF3, from a chemical structure of formula IIA-2 or a chemical structure of formula IIB-2 wherein RN# is selected from the group consisting of Me, iPr, tBu, CN, CF3 and Ph; wherein § represents the binding site of a single bond; and wherein Rb is selected independently from each other at each occurrence from the group consisting of H, Me, iPr, tBu, CN, CF3, Ph, which is optionally substituted by one or more substituents independently selected from the group consisting of Me, iPr, tBu, CN, CF3 and Ph, pyridinyl, which is optionally substituted by one or more substituents independently selected from the group consisting of Me, iPr, tBu, CN, CF3 and Ph, pyrimidinyl, which is optionally substituted by one or more substituents independently selected from the group consisting of Me, iPr, tBu, CN, CF3 and Ph, carbazolyl, which is optionally substituted by one or more substituents independently selected from the group consisting of Me, iPr, tBu, CN, CF3 and Ph, triazinyl, which is optionally substituted by one or more substituents independently selected from the group consisting of Me, iPr, tBu, CN, CF3 and Ph, and N(Ph)2.

2. Organic molecule according to claim 1, wherein R1 is independently from each other at each occurrence phenyl which is optionally substituted by one or more substituents R6, and R2 is selected independently from each other at each occurrence from the group consisting of hydrogen, CN, CF3, and phenyl which is optionally substituted by one or more substituents R6.

3. Organic molecule according to claim 1 or 2, comprising a structure selected from the group shown below:

4. Organic molecule according to one or more of claims 1 to 3, wherein Rb is independently selected at each occurrence from the group consisting of H and CN.

5. Organic molecule according to one or more of claims 1 to 4, comprising or consisting of a structure selected from the group shown below:

6. Method for producing an organic molecule according to claim 1 to 5, comprising the step of providing a 6-RB-substituted-3-bromocarbazole as a reactant.

7. Use of a molecule according to one or more of claims 1 to 5 as a luminescence emitter and / or transport material and / or hole injection material and / or hole blocking material in an optoelectronic device.

8. Use according to claim 7, wherein the optoelectronic device is selected from the group consisting of: • organic light emitting diodes (OLEDs), • light emitting electrochemical cells, • OLED sensors, • organic diodes, • organic solar cells, • organic transistors, • organic field effect transistors, • organic lasers and • down-conversion elements.

9. Composition, comprising: (a) an organic molecule according to one or more of claims 1 to 5, in particular in the form of an emitter, and (b) an emitter and / or host material which differs from the organic molecule according to one or more of claims 1 to 5, and (c) optionally a dye and / or a solvent.

10. Optoelectronic device, comprising an organic molecule according to one or more of claims 1 to 5 or a composition according to claim 9, in particular in the form of a device selected from the group consisting of organic light emitting diode (OLED), light emitting electrochemical cell, OLED sensor, organic diode, organic solar cell, organic transistor, organic field effect transistor, organic laser and down-conversion element.

11. Optoelectronic device according to claim 10, comprising - a substrate, - an anode and - a cathode, wherein the anode or the cathode are arranged on the substrate, and - a light-emitting layer arranged between the anode and the cathode and comprising an organic molecule according to one or more of claims 1 to 5 or a composition according to claim 9.

12. Method for producing an optoelectronic device, wherein an organic molecule according to one or more of claims 1 to 5 or a composition according to claim 9 is used.

13. Method according to claim 12, comprising processing the organic molecule or the organic composition by a vacuum evaporation process or from a solution.